- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02109133
The Impacts of Surgical Visibility Through Deep Neuromuscular Blockade on Intraocular Pressure in Patients Undergoing Robot-Assisted Laparoscopic Radical Prostatectomy
June 21, 2015 updated by: Yonsei University
Intraocular pressure is significantly increase during robot-assisted laparoscopic radical prostatectomy which is performed in a steep trendelenburg position at prolonged times of pneumoperitoneum.
Therefore investigators decided to evaluate the impacts of surgical visibility through deep neuromuscular blockade on intraocular pressure in patients undergoing Robot-Assisted Laparoscopic Radical Prostatectomy.
Study Overview
Status
Completed
Study Type
Interventional
Enrollment (Actual)
67
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Seoul, Korea, Republic of, 120-752
- Department of Anesthesiology and Pain Medicine, Yonsei University College of Medicine
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
50 years to 80 years (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Male
Description
Inclusion Criteria:
- ASA class I-II
- obtaining written informed consent from the parents
- aged over 50 years who were undergoing robot- assisted laparoscopic prostatectomy
Exclusion Criteria:
- eye surgery previously
- unstable angina or congestive heart failure
- concomitant eye disease (glaucoma, diabetic retinopathy, cataract, retinal detachment)
- high intraocular pressure over 30mmHg after screening test.
- uncontrolled hypertension (diastolic bp>110mmHg)
- coagulopathy
- asthma
- hepatic failure
- renal failure(creatinine clearance < 30 ml/min)
- drug hyperactivity
- neurological or psychiatric illnesses
- mental retardation
- patients who can't read the consent form due to illiterate or foreigner
- previous malignant hyperthermia Hx
- drug medication which interact with muscle relaxant (anti-convulsant, certain antibiotics, magnesium etc)
- BMI > 30kg/m2
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Deep neuromuscular blockade
|
deep neuromuscular blockade using rocuronium and reverse with sugammadex
|
Active Comparator: moderate neuromuscular blockade
|
moderate neuromuscular blockade using atracurium and reverse with neostigmine
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Maximum Intraocular Pressure During RALRP Under Deep Neuromuscular Blockade
Time Frame: Maximum intraocular pressure was measured at 60 minutes after CO2 pneumoperitoneum in the ST position
|
maximum intraocular pressure during RALRP under deep neuromuscular blockade after being positioned in the steep Trendelenburg position with CO2 pneumoperitoneum under deep neuromuscular blockade
|
Maximum intraocular pressure was measured at 60 minutes after CO2 pneumoperitoneum in the ST position
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Overall Surgical Condition
Time Frame: At the end of the Steep trendelenburg position, an average of 1 hour
|
overall surgical conditions using the 5-point rating scale as previously described: Grade 5 (optimal), optimal surgical conditions; grade 4 (good), nonoptimal conditions, but an intervention is not required; grade 3 (acceptable), wide surgical view, but an intervention can improve surgical conditions, grade 2 (poor), inadequate conditions, there is a visible view, but an intervention is necessary to ensure acceptable surgical conditions; grade 1 (extremely poor), inability to perform surgery; therefore, intervention is necessary.
|
At the end of the Steep trendelenburg position, an average of 1 hour
|
Other Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Post-operative Nausea
Time Frame: During 24hours after operation
|
During 24hours after operation
|
Incidence of Residual Neuromuscular Blockade
Time Frame: During 24hours after operation
|
During 24hours after operation
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
May 1, 2014
Primary Completion (Actual)
December 1, 2014
Study Completion (Actual)
December 1, 2014
Study Registration Dates
First Submitted
March 30, 2014
First Submitted That Met QC Criteria
April 8, 2014
First Posted (Estimate)
April 9, 2014
Study Record Updates
Last Update Posted (Estimate)
June 24, 2015
Last Update Submitted That Met QC Criteria
June 21, 2015
Last Verified
June 1, 2015
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Physiological Effects of Drugs
- Neurotransmitter Agents
- Molecular Mechanisms of Pharmacological Action
- Autonomic Agents
- Peripheral Nervous System Agents
- Cholinergic Antagonists
- Cholinergic Agents
- Enzyme Inhibitors
- Neuromuscular Agents
- Cholinesterase Inhibitors
- Nicotinic Antagonists
- Neuromuscular Nondepolarizing Agents
- Neuromuscular Blocking Agents
- Parasympathomimetics
- Rocuronium
- Neostigmine
- Atracurium
Other Study ID Numbers
- 4-2014-0058
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Robot-Assisted Laparoscopic Radical Prostatectomy
-
Seoul National University HospitalCompletedOptic Nerve Sheath Diameter | Robot Assisted Laparoscopic Radical ProstatectomyKorea, Republic of
-
Yonsei UniversityCompletedRobot-assisted Laparoscopic Radical Prostatectomy Undergoing General AnesthesiaKorea, Republic of
-
Yonsei UniversityCompletedRobotic-assisted Laparoscopic Radical ProstatectomyKorea, Republic of
-
Yonsei UniversityCompletedSteep Trendelenburg Position With Penumoperitoneum in Robot Assisted Laparoscopic Prostatectomy
-
Yonsei UniversityCompletedRobot-assisted Laparoscopic Prostatectomy Under General AnesthesiaKorea, Republic of
-
Yonsei UniversityCompletedRobot Assisted Laparoscopic ProstatectomyKorea, Republic of
-
University of California, San FranciscoCompletedMen With Prostate Cancer Undergoing Robot Assisted Radical ProstatectomyUnited States
-
University Hospital Hradec KraloveCompletedRobotic-assisted Radical ProstatectomyCzechia
-
Beijing Jishuitan HospitalUnknownthe Robot-assisted TechniqueChina
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityNot yet recruitingBladder Cancer | Robot-assisted Radical Cystectomy
Clinical Trials on Rocuronium
-
Radboud University Medical CenterMerck Sharp & Dohme LLCUnknown
-
Medtronic - MITGCompletedAnesthesia | Neuromuscular BlockadeUnited States
-
University of RostockCompletedObservation of Neuromuscular Block | Complication of Ventilation TherapyGermany
-
Sheba Medical CenterUnknown
-
Pontificia Universidad Catolica de ChileCompletedNeuromuscular Blockade
-
Rigshospitalet, DenmarkCompletedA Comparison of Rocuronium 0.3 mg/kg, and 0.9 mg/kg for Induction of Anesthesia in Elderly Patients.Anesthesia | Intubation Complication | Neuromuscular Blockade | Neuromuscular Blockade, ResidualDenmark
-
SMG-SNU Boramae Medical CenterUnknownSore ThroatKorea, Republic of
-
Merck Sharp & Dohme LLCCompleted
-
Asan Medical CenterCompletedNeuromuscular BlockadeKorea, Republic of
-
Memorial Sloan Kettering Cancer CenterRecruitingProstate CancerUnited States